medsynapse-hcp
Introduction Fibrodysplasia Ossificans Progressiva (FOP) is a rare genetic disorder causing progressive heterotopic ossification (HO) of soft tissues. Management remains largely supportive, with pharmacological interventions targeting the aberrant bone morphogenetic protein (BMP) signaling pathway (1). This article outlines pharmacological and adju
Management of FOP: Pharmacological & Supportive Approaches

Management of FOP: Pharmacological & Supportive Approaches

3414 Reached1 Comments

Similar Content

Case of Adolescent with Severe Macrocytic Anaemia
Case of Adolescent with Severe Macrocytic Anaemia
50824 Reached500 Comments51 Likes
Study to Test Tofacitinib Efficacy for Psoriatic Arthritis
Study to Test Tofacitinib Efficacy for Psoriatic Arthritis
446 Reached2 Comments4 Likes
Atypical Cellular Blue Nevus in a woman
Atypical Cellular Blue Nevus in a woman
93 Reached4 Comments1 Likes
Tofacitinib in Patients with Psoriatic Arthritis who have Inadequate Response to TNFi
Tofacitinib in Patients with Psoriatic Arthritis who have Inadequate Response to TNFi
127 Reached
Chronic Cough in Adolescent
Chronic Cough in Adolescent
282 Reached1 Comments6 Likes